76 related articles for article (PubMed ID: 22564734)
1. CGK733 enhances multinucleated cell formation and cytotoxicity induced by taxol in Chk1-deficient HBV-positive hepatocellular carcinoma cells.
Wang H; Zuo B; Wang H; Ren L; Yang P; Zeng M; Duan D; Liu C; Li M
Biochem Biophys Res Commun; 2012 May; 422(1):103-8. PubMed ID: 22564734
[TBL] [Abstract][Full Text] [Related]
2. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
[TBL] [Abstract][Full Text] [Related]
3. CGK733 does not inhibit ATM or ATR kinase activity in H460 human lung cancer cells.
Choi S; Toledo LI; Fernandez-Capetillo O; Bakkenist CJ
DNA Repair (Amst); 2011 Oct; 10(10):1000-1; author reply 1002. PubMed ID: 21865098
[No Abstract] [Full Text] [Related]
4. Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy.
Crescenzi E; Palumbo G; de Boer J; Brady HJ
Clin Cancer Res; 2008 Mar; 14(6):1877-87. PubMed ID: 18347191
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound activates ataxia telangiectasia mutated- and rad3-related (ATR)-checkpoint kinase 1 (Chk1) pathway in human leukemia Jurkat cells.
Furusawa Y; Iizumi T; Fujiwara Y; Hassan MA; Tabuchi Y; Nomura T; Kondo T
Ultrason Sonochem; 2012 Nov; 19(6):1246-51. PubMed ID: 22571845
[TBL] [Abstract][Full Text] [Related]
6. Enhancer of rudimentary homolog regulates DNA damage response in hepatocellular carcinoma.
Weng MT; Tung TH; Lee JH; Wei SC; Lin HL; Huang YJ; Wong JM; Luo J; Sheu JC
Sci Rep; 2015 Apr; 5():9357. PubMed ID: 25880358
[TBL] [Abstract][Full Text] [Related]
7. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
8. Multinucleation regulated by the Akt/PTEN signaling pathway is a survival strategy for HepG2 cells.
Mukherjee A; Misra S; Howlett NG; Karmakar P
Mutat Res; 2013 Aug; 755(2):135-40. PubMed ID: 23796964
[TBL] [Abstract][Full Text] [Related]
9. Defective DNA damage response and repair in liver cells expressing hepatitis B virus surface antigen.
Chung YL
FASEB J; 2013 Jun; 27(6):2316-27. PubMed ID: 23444429
[TBL] [Abstract][Full Text] [Related]
10. Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib.
Mao K; Zhang J; He C; Xu K; Liu J; Sun J; Wu G; Tan C; Zeng Y; Wang J; Xiao Z
Cancer Lett; 2014 Oct; 352(2):245-52. PubMed ID: 25034398
[TBL] [Abstract][Full Text] [Related]
11. Blockade of ataxia telangiectasia mutated sensitizes hepatoma cell lines to sorafenib by interfering with Akt signaling.
Fujimaki S; Matsuda Y; Wakai T; Sanpei A; Kubota M; Takamura M; Yamagiwa S; Yano M; Ohkoshi S; Aoyagi Y
Cancer Lett; 2012 Jun; 319(1):98-108. PubMed ID: 22265862
[TBL] [Abstract][Full Text] [Related]
12. Small molecule-based reversible reprogramming of cellular lifespan.
Won J; Kim M; Kim N; Ahn JH; Lee WG; Kim SS; Chang KY; Yi YW; Kim TK
Nat Chem Biol; 2006 Jul; 2(7):369-74. PubMed ID: 16767085
[TBL] [Abstract][Full Text] [Related]
13. Interaction of LHBs with C53 promotes hepatocyte mitotic entry: A novel mechanism for HBV-induced hepatocellular carcinoma.
Lei Y; Liu H; Yang Y; Wang X; Ren N; Li B; Liu S; Cheng J; Fu X; Zhang J
Oncol Rep; 2012 Jan; 27(1):151-9. PubMed ID: 21971960
[TBL] [Abstract][Full Text] [Related]
14. The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
Zhang R; Cao Y; Bai L; Zhu C; Li R; He H; Liu Y; Wu K; Liu F; Wu J
Mol Carcinog; 2015 Dec; 54(12):1554-66. PubMed ID: 25263696
[TBL] [Abstract][Full Text] [Related]
15. Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil.
Li W; Zhao XL; Shang SQ; Shen HQ; Chen X
Curr Cancer Drug Targets; 2015; 15(3):196-204. PubMed ID: 25643258
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
[TBL] [Abstract][Full Text] [Related]
17. Irradiation-induced G2/M checkpoint response requires ERK1/2 activation.
Yan Y; Black CP; Cowan KH
Oncogene; 2007 Jul; 26(32):4689-98. PubMed ID: 17297454
[TBL] [Abstract][Full Text] [Related]
18. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
19. The ATM and ATR inhibitors CGK733 and caffeine suppress cyclin D1 levels and inhibit cell proliferation.
Alao JP; Sunnerhagen P
Radiat Oncol; 2009 Nov; 4():51. PubMed ID: 19903334
[TBL] [Abstract][Full Text] [Related]
20. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
